| Caplin Point Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524742 |
NSE Symbol : CAPLIPOINT |
P/E(TTM) : 41.51 |
|
ISIN Demat : INE475E01026 |
Div & Yield% : 0.31 |
EPS(TTM) : 46.00 |
|
Book Value(₹) : 242.54 |
Market Cap(₹Cr) : 14,515.57 |
Face Value(₹) : 2.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 175.18 | 182.57 | 173.61 | 185.23 | 207.93 | 185.64 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 175.18 | 182.57 | 173.61 | 185.23 | 207.93 | 185.64 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 59.22 | 32.03 | 41.25 | 28.83 | 43.01 | 21.50 |
| Total Income | 234.40 | 214.60 | 214.86 | 214.06 | 250.94 | 207.14 |
| Total Expenditure | 99.33 | 95.96 | 98.57 | 107.84 | 109.77 | 104.26 |
| PBIDT | 135.07 | 118.64 | 116.29 | 106.22 | 141.17 | 102.88 |
| Interest | 0.05 | 0.04 | 0.04 | 0.04 | 0.02 | 0.02 |
| PBDT | 135.02 | 118.60 | 116.25 | 106.18 | 141.15 | 102.86 |
| Depreciation | 6.02 | 6.14 | 6.09 | 6.01 | 6.49 | 6.18 |
| Tax | 26.77 | 26.91 | 23.63 | 25.55 | 29.15 | 24.57 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.36 | -0.34 | 0.03 | -0.09 | -0.23 | -0.43 |
| Reported Profit After Tax | 102.59 | 85.89 | 86.50 | 74.71 | 105.74 | 72.54 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 102.59 | 85.89 | 86.50 | 74.71 | 105.74 | 72.54 |
| EPS (Unit Curr.) | 13.50 | 11.30 | 11.37 | 9.83 | 13.92 | 9.55 |
| EPS (Adj) (Unit Curr.) | 13.50 | 11.30 | 11.37 | 9.83 | 13.92 | 9.55 |
| Calculated EPS (Unit Curr.) | 13.50 | 11.30 | 11.38 | 9.83 | 13.91 | 9.54 |
| Calculated EPS (Adj) (Unit Curr.) | 13.50 | 11.30 | 11.38 | 9.83 | 13.91 | 9.54 |
| Calculated EPS (Ann.) (Unit Curr.) | 53.99 | 45.21 | 45.53 | 39.32 | 55.65 | 38.18 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 53.99 | 45.21 | 45.53 | 39.32 | 55.65 | 38.18 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 125.00 |
| Equity | 15.20 | 15.20 | 15.20 | 15.20 | 15.20 | 15.20 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 77.10 | 64.98 | 66.98 | 57.34 | 67.89 | 55.42 |
| PBDTM(%) | 77.08 | 64.96 | 66.96 | 57.32 | 67.88 | 55.41 |
| PATM(%) | 58.56 | 47.04 | 49.82 | 40.33 | 50.85 | 39.08 |